Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by KINGTRADER2on Mar 13, 2009 3:44am
255 Views
Post# 15842006

RE: Technology That May Save Lives

RE: Technology That May Save Lives

GOOD POST

''SSS has been fairly range-bound in terms of price since last May, when it reached 28.5 cents a share, before dipping down to two cents last November. In mid-March, the week of the Obama announcement that shined the spotlight on this sort of technology, the price sat around seven cents, still within bargain territory.''

Looks SSS will skyrocket very soon.. 0.2 in a month.. 0.5 in three months..

GLTA

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse